[Problems associated with molecular targeted drugs for cancer]
Makoto Kawaishi1, Fumiaki Koizum, Kazuto Nishio
1Shien Lab, Medical Oncology, National Cancer Center Hospital.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|October 13, 2006
Summary
Molecular targeted drugs offer cancer treatment advancements but face challenges in optimal dosing, patient selection, and target verification. Further research is crucial for clinical progress and addressing resistance and cost issues.
Area of Science:
- Oncology
- Pharmacology
- Biomarkers
Context:
- Molecular targeted drugs are integral to modern cancer therapy.
- Clinical application reveals challenges including optimal dosing, patient stratification, and target validation.
- Unexpected issues with efficacy, adverse events, and drug resistance necessitate further investigation.
Purpose:
- To highlight the ongoing challenges and essential research directions for molecular targeted cancer drugs.
- To emphasize the need for proof of principle (POP) studies and pharmacodynamic/pharmacogenomic research.
- To address the economic considerations associated with the development and application of these therapies.
Summary:
- Despite their role in cancer treatment, molecular targeted drugs present challenges in optimal use and efficacy.
- Proof of principle (POP) studies and advanced biomarker research are vital for overcoming clinical hurdles.
- Addressing issues like resistance, adverse events, and high costs is critical for future progress.
Impact:
- Informs the development of more effective and personalized cancer therapies.
- Guides future research priorities in targeted drug development and clinical trials.
- Contributes to a better understanding of the economic and clinical complexities of advanced cancer treatments.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...